Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Succinate-induced leukemic stem cell formation via epigenetic remodeling of hematopoietic stem cell

Descrizione del progetto

Infiammazione cronica: può portare alla leucemia?

Prove emergenti suggeriscono che il microambiente del midollo osseo potrebbe svolgere un ruolo attivo nello sviluppo di neoplasie ematologiche. In particolare, l’infiammazione cronica genera mediatori chiave che possono influenzare le cellule staminali ematopoietiche (HSC, haematopoietic stem cell), portando all’esaurimento della capacità di auto-rinnovamento e persino alla leucemia. Gli scienziati del progetto SuccHSC, finanziato dall’UE, si propongono di studiare il ruolo del succinato, una delle principali molecole effettrici indotte dall’infiammazione, che può raggiungere il nucleo e modificare gli istoni. I ricercatori studieranno l’impatto del succinato sulla modificazione dell’istone e sull’espressione genica in campioni normali e leucemici, fornendo informazioni sullo sviluppo della leucemia.

Obiettivo

In life, no matter how small, changes can have huge impact on its quality. For hematopoietic stem cells (HSC), similar can happen. Through minor shifts, from normal to pre-leukemic and finally leukemic phenotype, generation of leukemic stem cells (LSC) results in overt malignancy, such is acute myeloid leukemia (AML). Life quality of AML patients is severely impaired, even in “disease-free” state after the treatment. AML chemotherapy and stem cell transplant offers 5-year survival to only 20% of patients above age of sixty, 40% to the rest. Currently, a major clinical factor in AML onset and relapse are ever-present LSC. Mechanisms by which HSC turn into LSC, in their highly regulated environment, are still largely unknown, which is why new knowledge is needed to unveil this troubling issue. With the growing amount of data correlating chronic inflammation and onset of various types of malignancies, the SuccHSC project will explore the role of succinate, one of the major inflammation-induced effector molecules, in LSC formation by epigenetic remodeling of HSC. Chronic inflammation generates various molecules, which can be picked-up by bone marrow HSC. Chronic HSC activation leads to peripheral blood entering, myeloid skewing, self-renewal exaustion and even perhaps leukemia. On mechanistic side, HSC react to inflammatory mediators by elevated glycolysis, reduced oxygen and increased succinate. New succinate molecules can reach nucleus through mito-nuclear communication. Among other modifications, histones were shown to be modified with succinate, but yet with no known role. SuccHSC will explore histone succinylation and its effect on gene expression comparing leukemic and normal human samples biochemically, by ChIP-seq and by RNA-seq. Transgene succinate-dehydrogenase KO mice model, which accumulates succinate, will be used to confirm succinylation role in gene expression regulation and HSC transformation into pre-leukemic cell stage.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) H2020-MSCA-IF-2020

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET
Contributo netto dell'UE
€ 202 158,72
Costo totale
€ 202 158,72